Sparrow Bioacoustics has secured $10 million in funding to support the expansion of its smartphone-based cardiac artificial intelligence technology across the United States. According to the company, the investment will help accelerate commercialization and deployment efforts for its AI-powered platform designed to detect and monitor cardiac conditions through acoustic signals captured by mobile devices.
The company said that its technology leverages smartphone microphones to analyze heart sounds using advanced bioacoustic algorithms. The goal, according to Sparrow Bioacoustics, is to enable early detection of heart abnormalities without the need for specialized hardware, expanding access to cardiovascular screening and monitoring.
Sparrow Bioacoustics claims that the funding will also support continued clinical validation, partnerships with healthcare providers, and regulatory expansion efforts. The company noted that it is focused on integrating its technology into digital health ecosystems, allowing clinicians and patients to benefit from real-time insights into cardiac health.
According to the company, the financing reflects growing confidence in AI-enabled diagnostic tools aimed at reducing healthcare costs and improving accessibility. Sparrow Bioacoustics said that it plans to use the funds to scale its operations and further its mission of bringing advanced cardiac monitoring capabilities directly to consumers through everyday devices.
The post Sparrow Bioacoustics raises $10 million to expand cardiac AI rollout appeared first on Longevity.Technology – Latest News, Opinions, Analysis and Research.
